The number of billionaires in the UK has fallen at the highest rate in the 37 year... The chief executive of Novo Nordisk, the creator of obesity drugs Wegovy and Ozempic,... The Dutch business of ...

The S&P 500 is now on track for a five-day win streak, having erased all its 2025 losses as an air of normality returned to ...

Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its ...

LONDON (Reuters) -Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the ...

U.S. stock futures advance, U.S.-listed shares of Novo Nordisk fall on news its CEO is stepping down, and Charter Communications agrees to buy rival cable firm Cox. Here's what investors need to know ...

US Stock futures rise as the S&P 500 aims for a fifth straight gain, lifted by easing U.S.-China trade tensions and softer ...

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...

The Danish company said Jorgensen is leaving by mutual agreement with the board, though he’ll continue as chief 'for a period ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

Lars Fruergaard Jørgensen is stepping down as Novo Nordisk CEO, with the company citing the stock's recent struggles.

Novo Nordisk said today its CEO Lars Fruergaard Jorgensen will step down following a plunge in the company's share price amid intensifying competition in the obesity drug market.

U.S.-listed shares of Novo Nordisk declined in premarket trading Friday on the surprise news that CEO Lars Fruergaard ...